Dr. Charlot shares a description of the HapticsHealth™ technology being setup for a pilot study at the lab of John Caruso in the Department of Health & Sport Sciences at the University of Louisville.
AuraSense and the Caruso Lab are pioneering solutions to bring objective measurements for cognitive and physical status to people living with neurological conditions like Multiple Sclerosis (MS), Parkinson’s Disease (PD), Alzheimer’s Disease (AD/ADRD), and Epilepsy.
The goal is to address the current challenges in care associated with subjective and qualitative reporting of status leading to misdiagnosis and mistreatment. With objective measures, personalized and exacting diagnosis and treatment can be provided helping patients receive the care they need.